ANDOVER, Mass. & WASHINGTON--(BUSINESS WIRE)--Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bioscan, Inc. announced today that they have signed an agreement giving Philips Medical Systems co-marketing and co-distribution rights for Bioscan’s In-Vivo molecular imaging products, NanoSPECT and NanoSPECT/CT. The agreement covers countries in Europe, the Middle-East, Africa, Asia and Latin America.
